Update app.py

app.py

@@ -53,12 +53,33 @@ with gr.Blocks() as demo:
         title = gr.Textbox(label="Title", placeholder="Enter title")
         abstract = gr.Textbox(label="Abstract", placeholder="Enter abstract", lines=6)
 
+    # Examples for autofill
+    examples = [
+        [
+            "Effects of low-dose rivaroxaban combined with low-dose aspirin versus low-dose aspirin alone on in vivo platelet activation, endothelial function and inflammation in type 2 diabetes patients with stable atherosclerotic disease: the RivAsa randomized, crossover study",
+            """Aims: A very-low-dose regimen of the anti-factor Xa rivaroxaban combined with low-dose aspirin reduces vascular events more than aspirin alone in atherosclerotic patients, including those with type 2 diabetes (T2DM). Given the high platelet activation in T2DM patients, we investigated whether this combination reduces platelet activation versus aspirin alone and the possible mechanisms.
+
+Methods: Seventy-5 patients (12 females, aged 69 [65-72]), with stable atherothrombotic disease, on low-dose aspirin, participated in a randomized, cross-over, open-label, study with two arms: 4-week aspirin (100 mg once-daily) followed by 4-week aspirin plus rivaroxaban (2.5 mg twice-daily); 4-week aspirin plus rivaroxaban followed by 4-week aspirin. We investigated: in vivo platelet activation by urinary thromboxane A2 metabolite (TXM), thrombin generation (TG), endothelial function by urinary prostacyclin and plasma nitric oxide metabolites, lipid oxidation by urinary isoprostane, inflammation, coagulation biomarkers.
+
+Results: No carryover effects were observed. Rivaroxaban plus aspirin significantly reduced urinary TXM and isoprostane versus aspirin alone (20% [95 %CI:5-31 %] and 19% [12-26%], respectively, n = 73, p < 0.01). At rivaroxaban's maximal concentration, TG velocity index and peak were reduced by 44% [37-52%] and 81%[75-87%], respectively, versus aspirin alone. Inflammation and endothelial biomarkers were unchanged.
+
+Conclusions: Very-low-dose rivaroxaban and low-dose aspirin in T2DM patients significantly inhibit in vivo platelet function, TG and isoprostane formation. EudraCT Number: 2019-000610-10."""
+        ]
+        # Add more examples here if needed
+    ]
+
+    gr.Examples(
+        examples=examples,
+        inputs=[title, abstract],
+        label="Example Articles",
+        examples_per_page=1
+    )
+
     submit = gr.Button("Classify")
 
     def stream_chat(title_text, abstract_text):
         user_input = f"Title: {title_text.strip()}\nAbstract: {abstract_text.strip()}"
-        yield [(user_input, "")]  # show initial empty response
-
+        yield [(user_input, "")]  # initial blank output
         response_generator = stream_response(title_text, abstract_text)
         for update in response_generator:
             yield update